SEARCH

SEARCH BY CITATION

References

  • Alonso-Magdalena, P., Laribi, O., Ropero, A. B., Fuentes, E., Ripoll, C., Soria, B. et al. (2005) Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environmental Health Perspectives 113, 969977.
  • Baillie-Hamilton, P. F. (2002) Chemical toxins: a hypothesis to explain the global obesity epidemic. Journal of Alternative and Complementary Medicine 8, 185192.
  • Barker, D. J., Eriksson, J. G., Forsen, T. & Osmond, C. (2002) Fetal origins of adult disease: strength of effects and biological basis. International Journal of Epidemiology 31, 12351239.
  • Bern, H. (1992) The fragile fetus. In: Chemically-Induced Alterations in Sexual and Functioal Development: The Wildlife/Human Connection (eds T.Colborn & C.Clement), pp. 915. Princeton Scientific Publishing Co., Princeton.
  • Colborn, T. & Clement, C. (1992) Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific, Princeton.
  • Colborn, T., Vom Saal, F. S. & Soto, A. M. (1993) Developmental effects of endocrine-disrupting chemicals in wildlife and humans [see comments]. Environmental Health Perspectives 101, 378384.
  • Colborn, T., Dumanski, D. & Myers, J. P. (1996) Our Stolen Future. Penguin Books Inc., New York.
  • Collins, S. (2005) Overview of clinical perspectives and mechanisms of obesity. Birth Defects Research. Part A, Clinical and Molecular Teratology 73, 470471.
  • Dang, Z. C., Audinot, V., Papapoulos, S. E., Boutin, J. A. & Lowik, C. W. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. Journal of Biological Chemistry 278, 962967.
  • DHHS (2005) The Surgeon General’s call to action to prevent and decrease overweight and obesity. Available at: http://www.surgeongeneral.gov/topics/obesity.
  • Gesta, S., Bluher, M., Yamamoto, Y., Norris, A. W., Berndt, J., Kralisch, S. et al. (2006) Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proceedings of the National Academy of Sciences of the United States of America 103, 66766681.
  • Gillum, R. F. (1987) The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years. Journal of Chronic Diseases 40, 421428.
  • Gluckman, P. D. & Hanson, M. A. (2004) Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatric Research 56, 311317.
  • Grun, F. & Blumberg, B. (2006) Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(6 Suppl.), S50S55.
  • Hanson, M., Gluckman, P., Bier, D., Challis, J., Fleming, T., Forrester, T. et al. (2004) Report on the 2nd World Congress on Fetal Origins of Adult Disease, Brighton, U.K., June 7-10, 2003. Pediatric Research 55, 894897.
  • Heindel, J. J. (2003) Endocrine disruptors and the obesity epidemic. Toxicological Sciences 76, 247249.
  • Heindel, J. J. & Levin, E. (2005) Developmental origins and environmental influences – introduction. NIEHS symposium. Birth Defects Research. Part A, Clinical and Molecular Teratology 73, 469.
  • Herbst, A. L. & Bern, H. A. (1981) Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. Thieme-Stratton, New York.
  • Inadera, H. & Shimomura, A. (2005) Environmental chemical tributyltin augments adipocyte differentiation. Toxicology Letters 159, 226234.
  • Masuno, H., Kidani, T., Sekiya, K., Sakayama, K., Shiosaka, T., Yamamoto, H. et al. (2002) Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. Journal of Lipid Research 43, 676684.
  • Masuno, H., Okamoto, S., Iwanami, J., Honda, K., Shiosaka, T., Kidani, T. et al. (2003) Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells. Toxicological Sciences 75, 314320.
  • Masuno, H., Iwanami, J., Kidani, T., Sakayama, K. & Honda, K. (2005) Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicological Sciences 84, 319327.
  • McLachlan, J. A. (1985) Estrogens in the Environment. Elsevier Science Publishing Co., New York.
  • McLachlan, J. A. (1995) Estrogens in the Environment II. Elsevier, New York.
  • McLachlan, J. A., Newbold, R. R. & Bullock, B. C. (1980) Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Research 40, 39883999.
  • Mokdad, A. H., Serdula, M. K., Dietz, W. H., Bowman, B. A., Marks, J. S. & Koplan, J. P. (1999) The spread of the obesity epidemic in the United States, 1991–1998. Jama 282, 15191522.
  • Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S. et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama 289, 7679.
  • Newbold, R. (1995) Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environmental Health Perspectives 103 Suppl. 7, 8387.
  • Newbold, R. R., Bullock, B. C. & McLachlan, J. A. (1990) Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Research 50, 76777681.
  • Newbold, R. R., Padilla-Banks, E., Snyder, R. J. & Jefferson, W. N. (2005) Developmental exposure to estrogenic compounds and obesity. Birth Defects Research. Part A, Clinical and Molecular Teratology 73, 478480.
  • Newbold, R. R., Padilla-Banks, E. & Jefferson, W. N. (2006) Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147(6 Suppl.), S11S17.
  • Newbold, R., Padilla-Banks, E., Snyder, R. J., Phillips, T. M. & Jefferson, W. N. (2007a) Developmental exposure to endocrine disruptors and the obesity epidemic. Reproductive Toxicology 23, 290296.
  • Newbold, R. R., Padilla-Banks, E., Snyder, R. J. & Jefferson, W. N. (2007b) Perinatal exposure to environmental estrogens and the development of obesity. Molecular Nutrition & Food Research 51, 912917.
  • NIH (1992) NIH Workshop Long-Term Effects of Exposure to Diethylstilbestrol (DES). NIH, Falls Church, VA.
  • Oken, E. & Gillman, M. W. (2003) Fetal origins of obesity. Obesity Research 11, 496506.
  • Park, D., Huang, T. & Frishman, W. H. (2005) Phytoestrogens as cardioprotective agents. Cardiology in Review 13, 1317.
  • Penza, M., Montani, C., Romani, A., Vignolini, P., Pampaloni, B., Tanini, A. et al. (2006) Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147, 57405751.
  • Raun, A. P. & Preston, R. L. (2002) History of Diethylstilbestrol Use in Cattle, pp. 17. American Society of Animal Science, Savoy, IL, USA.
  • Sakurai, K., Kawazuma, M., Adachi, T., Harigaya, T., Saito, Y., Hashimoto, N. et al. (2004) Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. British Journal of Pharmacology 141, 209214.
  • Stettler, N., Stallings, V. A., Troxel, A. B., Zhao, J., Schinnar, R., Nelson, S. E., Ziegler, E. E. & Strom, B. L. (2005) Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 111, 18971903.
  • Tabb, M. M. & Blumberg, B. (2006) New modes of action for endocrine-disrupting chemicals. Molecular Endocrinology 20, 475482.